Sarepta Therapeutics Inc
(FRA:AB3A)
€
17.52
+0.74 (+4.32%)
Market Cap: 1.85 Bil
Enterprise Value: 2.08 Bil
PE Ratio: 0
PB Ratio: 1.42
GF Score: 61/100 Sarepta Therapeutics Inc (FRA:AB3A) Transcripts
- 1